智通财经APP获悉，摩根士丹利发布研报称，微创医疗(00853)公布去年业绩后，将其2025至2027年的销售预测分别下调6%、11%及14%，又将今明两年的每股盈测分别上调3%及5%，惟将2027年预测下调1%。该行料集团的营运现金流将于今年达到收支平衡，且净利润将于明年达至平衡。大摩将微创医疗目标价由8.5港元略微上调至8.6港元，维持“与大市同步”评级。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.